Investor Disposes 515.3 Million Neimeth Shares on Nigerian Exchange
A substantial shareholder in Neimeth International Pharmaceuticals Plc has sold a large block of the company’s shares on the Nigerian Exchange Limited (NGX), according to a recent regulatory filing.
In a notification filed with the NGX, Clinoscope Services Limited disclosed that it disposed of 515.3 million ordinary shares of Neimeth between 17 September and 19 December 2025. The transaction forms part of the firm’s disclosure obligations under market transparency rules.
The breakdown of the sale shows that 15.3 million shares were sold at ₦6.10 per share, while 500.0 million shares were disposed of at ₦6.00 per share, bringing the average price to approximately ₦6.05 per share.
Clinoscope Services Limited, identified in the filing as a substantial shareholder in Neimeth, completed the sale in compliance with post-trade transparency and corporate governance rules aimed at protecting investor confidence and maintaining market integrity.
Neimeth International Pharmaceuticals, a Nigerian healthcare company listed on the NGX, said the notification relates only to the shareholder’s sale and does not affect the company’s daily operations.
Market analysts suggest the sale comes amid an improved performance for Neimeth’s stock this year, following a strong run in 2025, though the long-term impact on the company’s share price and investor sentiment will depend on broader market conditions and future corporate developments.
